RxDoctor Payments Data

Bryan Batson, MD

Hypertension Specialist · Hattiesburg, MSNPI 1104840958

Payments from drug & device makers

What this record shows

This record is dominated by gifts: $47,780 of the $47,980 with a category attached, or 99.6%. Barco, Inc. accounts for 99.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $47,816 and has fallen 100.0% since, to $18 in 2025.

$47,980in general payments, 2019–2025

Across 10 payments — averaging $4797.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Barco, Inc.$48K
  • Siemens Medical Solutions USA, Inc.$124
  • Abbott$28
  • Edwards Lifesciences$25
  • Amgen$23
$229,189in research payments, 2019–2025

Across 51 payments — averaging $4493.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$229K

What the payments were for

  • Speaking & faculty fees$280%
  • Food & beverage$1720%
  • Gifts$47,780100%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Barco, Inc.1$47,780
Siemens Medical Solutions USA, Inc.6$124
Abbott1$28
Edwards Lifesciences1$25
Amgen1$23

How this compares

Too few hypertension specialist providers in Mississippito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$15,271
Medicare patients
84
Services billed
237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Spironolactone95$1,096
Losartan Potassium87$830
Irbesartan47$774
Amlodipine Besylate142$719
Metoprolol Succinate32$521
Labetalol Hcl16$520
Carvedilol72$435
Hydralazine Hcl37$273
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide12$171
Lisinopril22$128
Doxazosin Mesylate14$74
Chlorthalidone12$68
Furosemide12$63
Hydrochlorothiazide33$63
Tramadol Hcl12$37

Paid to pharmacies, not to this prescriber.

Other hypertension specialist in Hattiesburg

Where these figures come from

Is this you, or does something look wrong? →